These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2895004)

  • 21. Depletion of dopamine binding sites and changes in dopamine and dihydroxyphenylacetic acid levels in 17- and 90-day-old rat striatum after irreversible receptor antagonism.
    Crawford CA; McDougall SA; Rowlett JK; Bardo MT
    Neurosci Lett; 1992 Mar; 137(2):265-9. PubMed ID: 1350079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G; Norman AB; Newton PL; Creese I
    J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of D-1 dopamine receptors facilitates D-2 dopamine receptor recovery after irreversible receptor blockade.
    Cameron DL; Crocker AD
    Neuropharmacology; 1988 Apr; 27(4):447-50. PubMed ID: 2901675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential turnover rates of D1 dopamine receptors in the brain and retina of adult and senescent rats.
    Giorgi O; Pibiri MG; Dal Toso R; Toffano G; Biggio G
    Neurochem Int; 1992 Mar; 20 Suppl():171S-173S. PubMed ID: 1365420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of EEDQ on the dopamine D-1 receptor in vivo and in vitro.
    Andersen PH
    Eur J Pharmacol; 1988 Jul; 152(1-2):153-6. PubMed ID: 2905267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.
    McDougall SA; Crawford CA; Nonneman AJ
    Psychopharmacology (Berl); 1992; 106(4):502-10. PubMed ID: 1349753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a fast receptor turnover of D1 dopamine receptors in various forebrain regions of the rat.
    Fuxe K; Agnati LF; Merlo Pich E; Meller E; Goldstein M
    Neurosci Lett; 1987 Oct; 81(1-2):183-7. PubMed ID: 3320818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related assessment of central 5-HT1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Keck J; Lakoski JM
    Brain Res; 1996 Jul; 728(1):130-4. PubMed ID: 8864308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR
    Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
    Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
    Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockade.
    Neve KA; Loeschen S; Marshall JF
    Brain Res; 1985 Mar; 329(1-2):225-31. PubMed ID: 3156659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential turnover rates of D1 dopamine receptors in the retina and in distinct areas of the rat brain.
    Giorgi O; Pibiri MG; Biggio G
    J Neurochem; 1991 Sep; 57(3):754-9. PubMed ID: 1677675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity.
    Meller E; Enz A; Goldstein M
    Eur J Pharmacol; 1988 Oct; 155(1-2):151-4. PubMed ID: 2907486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of the receptor turnover using an irreversible inactivating method. Theoretical assumptions, limitations and practical realization.
    Nowak G
    Pol J Pharmacol Pharm; 1990; 42(5):433-40. PubMed ID: 1983029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E; Bohmaker K; Namba Y; Friedhoff AJ; Goldstein M
    Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery of alpha 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Adler CH; Meller E; Goldstein M
    Eur J Pharmacol; 1985 Oct; 116(1-2):175-8. PubMed ID: 2865161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.